Biotherapy present specifics risks that patients must know and learn to manage. A national survey has been carried in this study to evaluate patients safety skills. (wording: " cross study of safety skills of 677 patients treat by biopharmaceuticals for an inflammatory rheumatism). This survey has allowed showcasing patients difficulties in managing their treatment, including for those under subcutaneous biotherapy. More than 60% patients interviewed doesn't know symptoms to bring them to consult and mainly postpone to their injection. The aim of this study is to prove that nursing consultation can allow the patient to become independent in treatment management and thus avoid occurrence of adverse event.

Inclusion Criteria:

• Patient suffering from rheumatoid arthritis followed by Rheumatology consultation of Amiens-Picardie University Hospital
• Patient treated by Subcutaneous Biotherapy for at least 6 months at the time of inclusion
• Major patient
• Patient having signed an informed consent

Exclusion Criteria:

• Minor patient
• Patient with cognitive impairment diagnosed by a physician
• Patient under tutorship or curatorship
• Patient deaf or hard of hearing
• Patient not fluent in the French language (at the decision of the investigator)